COVID‐19 Patients Have Peripheral Microvascular Dysfunction and Tissue Hypoxia in Spite of Successful Treatment of Lung Failure: A Proof of Concept Study
Results show skin microvascular dysregulation and tissue hypoxia in patients, indicative of hypoxia also in other tissues. We hypothesize that tissue hypoxia is a cause of reversible and non-reversible long COVID-19 symptoms and of mortality.
Authors
- Aaron D. Aguirre (ORCID: https://orcid.org/0000-0002-5509-1646)
- Andrea Jaramillo (ORCID: https://orcid.org/0000-0001-5574-0274)
- Kamila Drezek (ORCID: https://orcid.org/0000-0002-8560-6604)
- Luigino Capone
- Maged Helmy
- Knut Kvernebo (ORCID: https://orcid.org/0000-0001-8262-5829)
- Yunong Zhao (ORCID: https://orcid.org/0000-0003-2439-8669)
- David D’Alessandro
- L. Liv Kristin Wikslund
Institutions
- Oslo University Hospital (NO)
- Harvard University (US)
- University of Oslo (NO)
- Massachusetts General Hospital (US)
- Østfold Hospital Trust (NO)
Publication Details
- Journal
- Microcirculation
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1111/micc.70014
- Citations
- 1
- Primary Topic
- Respiratory Support and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 1.52